Project Grant H79TI088000

Award Date 9/30/24
Completion Date 9/29/29
Dollars Obligated $280K
Federal Grant Program
93.243
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This $86,879,418 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program aims to expand and sustain treatment, recovery support, and prevention services for individuals with opioid use disorder (OUD) in high-need areas of Georgia. The funding will serve an estimated 4,800 individuals with OUD over the 3-year project period, while also...
This $400,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program aims to expand trauma-informed substance use disorder (SUD) treatment, recovery, and reentry services for 18-35 year-old Latinx, Black/African American, and LGBTQIA2S+ adults with SUD and/or co-occurring mental disorders in Los Angeles County. The five-year project,...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,500,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Atlanta / Fulton County Prearrest Diversion Initiative, Inc. The grant, which will be distributed over a 5-year period from September 30, 2024 to September 29, 2029, will support the organization's Care Navigation services to provide outreach, case management,...
The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration (SAMHSA) Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, has awarded a $500,000 Project Grant to Erise Williams and Associates, Inc. The grant, titled "STL MADE: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at Risk for HIV/AIDS," will be used to extend an existing program and...
The U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $487,461 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Native Health, a non-profit minority-owned healthcare organization in Phoenix, Arizona. The grant funds a 5-year pilot project to implement an integrated health and outreach program for HIV, hepatitis C, sexually...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $750,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Behavioral Health Services of South Georgia, doing business as Legacy Behavioral Health Services. The grant supports a strategic prevention framework to address substance misuse among children in grades 6-12 across a 10-county rural region in South Georgia. The key...
This Project Grant award, valued at $1,555,700.00 and spanning 9/30/2024 to 9/29/2029, is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The award will enable the Morehouse School of Medicine, a private non-profit historically black medical school in Atlanta, Georgia, to provide evidence-based training, technical assistance, and other...
This $500,000 federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program supports Aids Alabama Inc.'s "Living in Balance" project. The project aims to implement an integrated care model that provides comprehensive services to people with HIV/AIDS and substance use disorders in the greater Birmingham, Alabama area. Key...
This federal Project Grant award, totaling $375,000, was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant recipient, Southern Healthcare Collaboration, Inc., will use the funding to implement the "Mind, Body & Soul" initiative, which aims to address substance abuse, mental health challenges, and healthcare access...
This Project Grant award of $600,000 from the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) federal grant program will allow Georgia Highlands Medical Services, Inc. to expand its integrated mental health and substance use disorder services, including the provision of medication-assisted treatment for opioid use disorder. The funding will enable Georgia Highlands Medical Services to hire two additional clinical counselors, a psychiatric...

This $280,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) will enable Westcare Georgia, Inc. to provide substance use disorder (SUD) prevention, SUD treatment, and HIV/STI/viral hepatitis prevention services, testing, vaccination, and linkage to care for youth and adults aged 13 and older in the Atlanta metropolitan area. Key objectives include providing HIV counseling, testing, and linkage to 900 individuals; hepatitis C testing to 650 individuals; syphilis testing to 450 individuals; and substance use prevention or SUD/co-occurring treatment to 400 individuals, with a focus on vulnerable populations such as gay/bisexual men, racial/ethnic minorities, and people who inject drugs. The program aims to improve functioning, reduce risk-taking behaviors, and increase knowledge related to transmission of HIV, hepatitis, and STDs.

Generated 6/24/25, 5:28 AM